Pacira BioSciences
PCRX
PCRX
257 hedge funds and large institutions have $2.9B invested in Pacira BioSciences in 2020 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 92 increasing their positions, 84 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2.73% less ownership
Funds ownership: 115.66% → 112.93% (-2.7%)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
59% less call options, than puts
Call options by funds: $2.95M | Put options by funds: $7.13M
Holders
257
Holding in Top 10
5
Calls
$2.95M
Puts
$7.13M
Top Buyers
| 1 | +$26M | |
| 2 | +$25.3M | |
| 3 | +$18M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$17.9M |
| 5 |
SCM
Spyglass Capital Management
San Francisco,
California
|
+$17M |
Top Sellers
| 1 | -$28M | |
| 2 | -$27M | |
| 3 | -$21.7M | |
| 4 |
HM
HealthCor Management
New York
|
-$21.3M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$10.5M |